332 related articles for article (PubMed ID: 29026395)
21. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
22. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R
PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166
[TBL] [Abstract][Full Text] [Related]
23. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
[TBL] [Abstract][Full Text] [Related]
24. A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study.
Lee SS; Lin HH; Tsai HC; Su IJ; Yang CH; Sun HY; Hung CC; Sy CL; Wu KS; Chen JK; Chen YS; Fang CT
PLoS One; 2015; 10(8):e0135801. PubMed ID: 26280669
[TBL] [Abstract][Full Text] [Related]
25. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
[TBL] [Abstract][Full Text] [Related]
26. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015.
Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S
AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106
[TBL] [Abstract][Full Text] [Related]
27. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India.
Alvarez-Uria G; Pakam R; Midde M; Naik PK
J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123
[TBL] [Abstract][Full Text] [Related]
28. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.
Martinson NA; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray GE; Chaisson RE; McIntyre JA; Meyers T
Int J Tuberc Lung Dis; 2009 Jul; 13(7):862-7. PubMed ID: 19555536
[TBL] [Abstract][Full Text] [Related]
29. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
Gezae KE; Abebe HT; Gebretsadik LG
BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
[TBL] [Abstract][Full Text] [Related]
30. Tuberculosis and its association with CD4
Geremew D; Melku M; Endalamaw A; Woldu B; Fasil A; Negash M; Baynes HW; Geremew H; Teklu T; Deressa T; Tessema B; Sack U
BMC Infect Dis; 2020 May; 20(1):325. PubMed ID: 32380957
[TBL] [Abstract][Full Text] [Related]
31. Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model.
Gatechompol S; Sophonphan J; Ubolyam S; Avihingsanon A; van Leth F; Cobelens F; Kerr SJ
BMC Infect Dis; 2022 Apr; 22(1):346. PubMed ID: 35387594
[TBL] [Abstract][Full Text] [Related]
32. Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?
Pettit AC; Jenkins CA; Stinnette SE; Rebeiro PF; Blackwell RB; Raffanti SP; Shepherd BE; Sterling TR
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):305-10. PubMed ID: 21423024
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.
Mugusi SF; Ngaimisi E; Janabi MY; Mugusi FM; Minzi OM; Sasi PG; Bakari M; Lindquist L; Aklillu E; Sandstrom EG
Antivir Ther; 2012; 17(2):265-74. PubMed ID: 22293579
[TBL] [Abstract][Full Text] [Related]
34. Risk of Active Tuberculosis in HIV-Infected Patients in Taiwan with Free Access to HIV Care and a Positive T-Spot.TB Test.
Sun HY; Hsueh PR; Liu WC; Su YC; Chang SY; Hung CC; Chang SC
PLoS One; 2015; 10(5):e0125260. PubMed ID: 25938227
[TBL] [Abstract][Full Text] [Related]
35. Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
Anígilájé EA; Aderibigbe SA; Adeoti AO; Nweke NO
PLoS One; 2016; 11(5):e0156177. PubMed ID: 27232185
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.
Haile D; Takele A; Gashaw K; Demelash H; Nigatu D
PLoS One; 2016; 11(10):e0164299. PubMed ID: 27716827
[TBL] [Abstract][Full Text] [Related]
37. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
Van Rie A; Westreich D; Sanne I
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):349-55. PubMed ID: 20926954
[TBL] [Abstract][Full Text] [Related]
38. Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes.
Monge S; Diez M; Pulido F; Iribarren JA; Campins AA; Arazo P; Montero M; Miro JM; Moreno S; Del Amo J;
Int J Tuberc Lung Dis; 2014 Jun; 18(6):700-8. PubMed ID: 24903942
[TBL] [Abstract][Full Text] [Related]
39. Factors Associated with Mortality of TB/HIV Co-infected Patients in Ethiopia.
Teklu AM; Nega A; Mamuye AT; Sitotaw Y; Kassa D; Mesfin G; Belayihun B; Medhin G; Yirdaw K
Ethiop J Health Sci; 2017 Feb; 27(Suppl 1):29-38. PubMed ID: 28465651
[TBL] [Abstract][Full Text] [Related]
40. Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.
Bachmann MO; Timmerman V; Fairall LR
AIDS; 2015 Nov; 29(17):2261-8. PubMed ID: 26544699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]